HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 212 filers reported holding HERBALIFE LTD in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $88,280,000 | -29.6% | 2,907,762 | -5.1% | 5.91% | -9.7% |
Q4 2021 | $125,359,000 | -1.3% | 3,062,762 | +2.2% | 6.54% | +8.1% |
Q3 2021 | $126,990,000 | +20.6% | 2,996,462 | +50.1% | 6.05% | +35.2% |
Q2 2021 | $105,273,000 | +18.9% | 1,996,462 | 0.0% | 4.48% | -1.0% |
Q1 2021 | $88,563,000 | +29.3% | 1,996,462 | +40.1% | 4.52% | +19.2% |
Q4 2020 | $68,493,000 | +3.0% | 1,425,462 | 0.0% | 3.80% | -17.7% |
Q3 2020 | $66,498,000 | +3.7% | 1,425,462 | 0.0% | 4.61% | -33.2% |
Q2 2020 | $64,117,000 | +54.3% | 1,425,462 | 0.0% | 6.90% | -24.5% |
Q1 2020 | $41,566,000 | -26.4% | 1,425,462 | +20.4% | 9.14% | -1.6% |
Q4 2019 | $56,446,000 | +31.9% | 1,184,108 | +4.7% | 9.28% | -1.8% |
Q3 2019 | $42,800,000 | -11.5% | 1,130,482 | 0.0% | 9.45% | -23.7% |
Q2 2019 | $48,339,000 | -19.3% | 1,130,482 | 0.0% | 12.38% | -30.8% |
Q1 2019 | $59,904,000 | -10.1% | 1,130,482 | 0.0% | 17.90% | -29.2% |
Q4 2018 | $66,642,000 | +8.1% | 1,130,482 | 0.0% | 25.29% | +34.9% |
Q3 2018 | $61,668,000 | +1.6% | 1,130,482 | 0.0% | 18.74% | -11.1% |
Q2 2018 | $60,684,000 | +10.1% | 1,130,482 | +100.0% | 21.09% | -12.3% |
Q1 2018 | $55,094,000 | +43.9% | 565,241 | 0.0% | 24.05% | +14.2% |
Q4 2017 | $38,278,000 | – | 565,241 | – | 21.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |